SEER
Seer, Inc.
There isn't enough reported data to score SEER yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
SEER Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Weak | |
| Unavailable |
SEER's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
SEER PE Valuation
SEER has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
SEER Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect SEER's losses to shrink, with revenue growing.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
SEER Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.15 | +$0.21 |
| Q2 2026 | -$1.22 | +$0.17 |
| Q1 2026 | -$1.24 | +$0.17 |
| Q4 2025 | -$1.28 | +$0.11 |
| Q3 2025 | -$1.36 | -$0.07 |
| Q2 2025 | -$1.39 | -$0.12 |
| Q1 2025 | -$1.41 | -$0.12 |
| Q4 2024 | -$1.39 | -$0.04 |
SEER is still losing money, but less than at its worst: $1.15 per share over the past year, against $1.49 at its worst in late 2022.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over SEER on earnings quality, reporting a profit while its opponent remains loss making.
SEER Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4M | +0.3% |
| Q2 2026 | $3.1M | -21% |
| Q1 2026 | $2.8M | -33% |
| Q4 2025 | $4.2M | +5% |
| Q3 2025 | $4M | -1.6% |
| Q2 2025 | $3.9M | +28% |
| Q1 2025 | $4.1M | +35% |
| Q4 2024 | $4M | -9.9% |
SEER's revenue is down over the past year, though its latest quarter was up: $4M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -368% | +119 points |
| Q2 2026 | -543% | -21 points |
| Q1 2026 | -618% | -118 points |
| Q4 2025 | -414% | +173 points |
| Q3 2025 | -487% | +116 points |
| Q2 2025 | -522% | +360 points |
| Q1 2025 | -500% | +322 points |
| Q4 2024 | -587% | -86 points |
SEER's operating margin was −368% last quarter, up 119 points from the same quarter a year ago, near the top of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over SEER on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over SEER on profitability, with a higher operating margin.
SEER Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$10M | -$2.1M |
| Q2 2026 | -$9.6M | +$5.6M |
| Q1 2026 | -$15.7M | -$3.6M |
| Q4 2025 | -$11.1M | -$178K |
| Q3 2025 | -$7.8M | +$8.5M |
| Q2 2025 | -$15.2M | -$4M |
| Q1 2025 | -$12.1M | -$861K |
| Q4 2024 | -$10.9M | +$1.1M |
SEER has burned cash in almost every quarter: −$46M over the past year, against −$46M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over SEER on cash generation, producing positive trailing cash flow while its opponent burns cash.
SEER Net Leverage
SEER's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
SEER Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 4.7 | Oversold |
SEER's weekly RSI is 39 (neutral) and its Stochastic is 5 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
SEER PE vs Healthcare Sector
SEER has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
SEER Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.91 | 17% below |
| 20 week MA | $1.97 | 19% below |
| 50 week MA | $1.88 | 15% below |
| 100 week MA | $2.00 | 20% below |
| 200 week MA | $2.32 | 31% below |
SEER is in a downtrend: it's below all five of its weekly moving averages, and 31% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over SEER on trend strength, trading above more of its moving averages.
SEER Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $56.5 | $62.0 | +9.9% |
| 2021 | $62.0 | $23.8 | -62% |
| 2022 | $23.8 | $5.65 | -76% |
| 2023 | $5.65 | $1.94 | -66% |
| 2024 | $1.94 | $2.26 | +16% |
| 2025 | $2.26 | $1.84 | -19% |
| 2026 YTD | $1.84 | $1.59 | -14% |
SEER has finished lower in four of the last six years. It's down 14% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over SEER on returns for 2026, with the stronger performance.